Evidence map›Paper›PMID 40249131›Full record

ArticleAdvanced healthcare materials2025

Imine Crosslinked, Injectable, and Self-Healing Fucoidan Hydrogel with Immunomodulatory Properties.

Asma Talib Qureshi, Shajia Afrin, Saad Asim, Muhammad Rizwan

Abstract read
In one paragraph

Article in Advanced healthcare materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. On-Demand Chemically Degradable Hydrogels for Biological Applications.Chembiochem : a European journal of chemical biology · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Asma Talib QureshiDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, 75235, USA.ORCID 0009-0009-1612-5215
Shajia AfrinDepartment of Biomedical Engineering, Michigan Technological University, Houghton, MI, 49931, USA.ORCID 0009-0002-5908-3704
Saad AsimDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, 75235, USA.
Muhammad RizwanDepartment of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, 75235, USA.

Funding

Bioengineered corneal endothelial graft using photodegradable device to induce graft-host integrationR01EY035305 · NEI · UT SOUTHWESTERN MEDICAL CENTER · PI Muhammad Rizwan · 2023 to 2026
$1.5M
NEI NIH HHS R01 EY035305NEI NIH HHS R01EY035305
6 · The paper itself

Abstract

Biomaterials with inherent anti-inflammatory properties and the ability to foster a pro-regenerative environment hold significant promise for enhancing cell transplantation and tissue regeneration. Fucoidan, a sulfated polysaccharide with well-documented immune-regulatory and antioxidant capabilities, offers strong potential for creating such biomaterials. Yet, there is a lack of engineered fucoidan hydrogels that are injectable and provide tunable physicochemical properties. In this study, the ability of fucoidan to undergo periodate-mediated oxidation is leveraged to introduce aldehydes into backbone (oxidized fucoidan, OFu), enabling the formation of reversible, imine-crosslinks with amine-containing molecules such as gelatin. The imine-crosslinked OFu-gelatin hydrogel provided excellent control over gelation rate and mechanical properties. Counter-intuitively, OFu-gelatin hydrogel exhibited excellent long-term stability (≥28 days), even though imine crosslinks are known to be relatively less stable. Moreover, the OFu-gelatin hydrogels are self-healing, injectable, and biocompatible, supporting cell culture and encapsulation. Furthermore, fucoidan hydrogels displayed immune-modulatory properties both in vitro and in vivo. This innovative injectable fucoidan hydrogel presents a versatile platform for applications in tissue engineering and regenerative medicine.

Indexed as

HydrogelsIminesPolysaccharidesAnimalsBiocompatible MaterialsCross-Linking ReagentsGelatinHumansInjectionsMiceBiocompatible MaterialsCross-Linking ReagentsfucoidanGelatinHydrogelsIminesPolysaccharidesfucoidanhydrogelimmunomodulationinjectableself‐healing

Identifiers

PMID40249131
PMCPMC12147990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.